Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
2.900
-0.540 (-15.70%)
Mar 31, 2025, 1:15 PM EDT - Market open
Silence Therapeutics Stock Forecast
SLN's stock price has decreased by -86.57% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Silence Therapeutics stock have an average target of 40.8, with a low estimate of 4.00 and a high estimate of 75. The average target predicts an increase of 1,306.90% from the current stock price of 2.90.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Silence Therapeutics stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 2 | 2 | 2 | 2 | 1 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 1 | 1 |
Total | 4 | 4 | 4 | 4 | 4 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +2,486.21% | Mar 7, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $49 → $45 | Buy | Maintains | $49 → $45 | +1,451.72% | Mar 5, 2025 |
BMO Capital | BMO Capital | Buy Maintains $67 → $25 | Buy | Maintains | $67 → $25 | +762.07% | Mar 4, 2025 |
Goldman Sachs | Goldman Sachs | Strong Sell Maintains $6 → $4 | Strong Sell | Maintains | $6 → $4 | +37.93% | Mar 4, 2025 |
Goldman Sachs | Goldman Sachs | Strong Sell Initiates $6 | Strong Sell | Initiates | $6 | +106.90% | Feb 11, 2025 |
Financial Forecast
Revenue This Year
32.34M
from 43.26M
Decreased by -25.23%
Revenue Next Year
n/a
from 32.34M
EPS This Year
n/a
from -0.98
EPS Next Year
n/a
Revenue Forecast
Revenue | 2025 |
---|---|
High | 74.5M |
Avg | 32.3M |
Low | 10.3M |
Revenue Growth
Revenue Growth | 2025 |
---|---|
High | 72.2% |
Avg | -25.2% |
Low | -76.3% |
EPS Forecast
EPS |
---|
High |
Avg |
Low |
EPS Growth
EPS Growth |
---|
High |
Avg |
Low |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.